These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32125680)
1. Controversies in the therapeutic approach to congenital cytomegalovirus infection. Garrido-Barbero M; Arnaez J; Garcia-Alix A Infection; 2020 Jun; 48(3):463-469. PubMed ID: 32125680 [TBL] [Abstract][Full Text] [Related]
2. Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection. Alarcon A; Garcia-Alix A; Cabañas F; Hernanz A; Pascual-Salcedo D; Martin-Ancel A; Cabrera M; Tagarro A; Quero J Eur J Pediatr; 2006 Sep; 165(9):636-45. PubMed ID: 16691400 [TBL] [Abstract][Full Text] [Related]
3. Successful valganciclovir treatment initiated beyond 60 days of age in a preterm infant with congenital cytomegalovirus disease. Okahashi A; Hijikata M; Seimiya A; Nagano N; Yokota H; Kimura Y; Morioka I Pediatr Int; 2024; 66(1):e15755. PubMed ID: 38563289 [No Abstract] [Full Text] [Related]
4. 10-year follow-up of congenital cytomegalovirus infection complicated with severe neurological findings in infancy: a case report. Suganuma E; Oka A; Sakata H; Adachi N; Asanuma S; Oguma E; Yamaguchi A; Furuichi M; Uejima Y; Sato S; Takano T; Kawano Y; Tanaka R; Arai T; Oh-Ishi T BMC Pediatr; 2018 Nov; 18(1):369. PubMed ID: 30470211 [TBL] [Abstract][Full Text] [Related]
5. Changes in Valganciclovir Use Among Infants with Congenital Cytomegalovirus Diagnosis in the United States, 2009-2015 and 2016-2019. Leung J; Grosse SD; Hong K; Pesch MH; Lanzieri TM J Pediatr; 2022 Jul; 246():274-278.e2. PubMed ID: 35358586 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of a flow chart for targeted screening of congenital cytomegalovirus-related hearing loss. Ciccia M; Monari C; Vitagliano G; Zarro N; Sandri F J Neonatal Perinatal Med; 2018; 11(3):339-343. PubMed ID: 30040746 [TBL] [Abstract][Full Text] [Related]
7. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study. Bartlett AW; Hall BM; Palasanthiran P; McMullan B; Shand AW; Rawlinson WD J Clin Virol; 2018 Nov; 108():121-125. PubMed ID: 30300787 [TBL] [Abstract][Full Text] [Related]
8. Congenital cytomegalovirus infection: current strategies and future perspectives. Buonsenso D; Serranti D; Gargiullo L; Ceccarelli M; Ranno O; Valentini P Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):919-35. PubMed ID: 22953641 [TBL] [Abstract][Full Text] [Related]
9. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection. Yilmaz Çiftdogan D; Vardar F J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693 [TBL] [Abstract][Full Text] [Related]
15. Valganciclovir therapy for a neonate with congenital cytomegalovirus pneumonitis. Kanda R; Shimizu D; Hoshina T; Ogawa M; Kusuhara K Pediatr Int; 2021 Dec; 63(12):1526-1528. PubMed ID: 34399019 [No Abstract] [Full Text] [Related]
16. Congenital cytomegalovirus - who, when, what-with and why to treat? Lim Y; Lyall H J Infect; 2017 Jun; 74 Suppl 1():S89-S94. PubMed ID: 28646968 [TBL] [Abstract][Full Text] [Related]
17. Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection. Natale F; Bizzarri B; Cardi V; Gaeta A; Villani P; Liuzzi G; De Curtis M Ital J Pediatr; 2015 Mar; 41():26. PubMed ID: 25888518 [TBL] [Abstract][Full Text] [Related]
18. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss. Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391 [TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Amir J; Wolf DG; Levy I Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081 [TBL] [Abstract][Full Text] [Related]